These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Mild form of the Hunter syndrome, indentity of the biochemical defect with the severe type. Wiesmann UN; Rampini S Helv Paediatr Acta; 1974 Apr; 29(1):73-8. PubMed ID: 4275601 [No Abstract] [Full Text] [Related]
27. [Follow-up of patients with Hunter syndrome: the Hunter Outcome Survey (HOS) registry]. del Toro-Riera M Rev Neurol; 2007 Feb; 44 Suppl 1():S13-7. PubMed ID: 17345554 [TBL] [Abstract][Full Text] [Related]
28. [Clinical aspects of mucopolysaccharidosis type II]. Sanjurjo-Crespo P Rev Neurol; 2007 Feb; 44 Suppl 1():S3-6. PubMed ID: 17345555 [TBL] [Abstract][Full Text] [Related]
30. Portal hypertension in a patient with Hunter disease. Kato T; Isogai K; Orii K; Kuratsubo I; Kondo N; Orii T; Suzuki Y J Inherit Metab Dis; 2006 Oct; 29(5):686. PubMed ID: 16972178 [TBL] [Abstract][Full Text] [Related]
31. Natural history of extensive Mongolian spots in mucopolysaccharidosis type II (Hunter syndrome): a survey among 52 Japanese patients. Ochiai T; Suzuki Y; Kato T; Shichino H; Chin M; Mugishima H; Orii T J Eur Acad Dermatol Venereol; 2007 Sep; 21(8):1082-5. PubMed ID: 17714129 [TBL] [Abstract][Full Text] [Related]
32. Hydrocephalus in Hunter Syndrome. van Aerde J; Plets C; Van der Hauwaert L Acta Paediatr Belg; 1981; 34(2):93-6. PubMed ID: 6801919 [No Abstract] [Full Text] [Related]
33. Multidisciplinary management of Hunter syndrome. Muenzer J; Beck M; Eng CM; Escolar ML; Giugliani R; Guffon NH; Harmatz P; Kamin W; Kampmann C; Koseoglu ST; Link B; Martin RA; Molter DW; Muñoz Rojas MV; Ogilvie JW; Parini R; Ramaswami U; Scarpa M; Schwartz IV; Wood RE; Wraith E Pediatrics; 2009 Dec; 124(6):e1228-39. PubMed ID: 19901005 [TBL] [Abstract][Full Text] [Related]
34. What syndrome is this? Hunter syndrome (mucopolysaccharidosis II). Panine VV; Hashimoto K Pediatr Dermatol; 1995 Dec; 12(4):370-2. PubMed ID: 8747590 [No Abstract] [Full Text] [Related]
35. [X-linked dilated cardiomyopathy: a cardiospecific phenotype of dystrophinopathy]. Yoshida K; Takeda S Ryoikibetsu Shokogun Shirizu; 2001; (35):23-7. PubMed ID: 11555918 [No Abstract] [Full Text] [Related]
36. [Guideline for diagnosis, follow-up and treatment of mucopolysaccharidoses type II or Hunter disease]. Grupo de Trabajo de Enfermedades poco frecuentes Arch Argent Pediatr; 2011 Apr; 109(2):175-81. PubMed ID: 21591474 [No Abstract] [Full Text] [Related]
37. [Type II mucolipidosis]. Maroteaux P; Hors-Cayla MC; Pont J Presse Med (1893); 1970 Jan; 78(4):179-81. PubMed ID: 4244747 [No Abstract] [Full Text] [Related]